Even when the House Energy and Commerce 21st Century Cures Initiative takes on topics that span the wider healthcare industry infrastructure and might seem more geared towards discussions of what constitutes a medical device or how to advance electronic health records, lawmakers seem to find a way to bring the drug development and approval process to the table.
Such was the case when House Energy and Commerce Health Subcommittee Chair Joseph Pitts, R-Pa., pressed Amazon VP of Global Public Policy Paul Misener July 17 on ways Congress could...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?